Phytosomes - An emerging approach for effective management of Dermatological Disorder
Article Sidebar
-
Phytosomes, herbal extracts, antiaging, dosage form, bioavailability
Abstract
The word ”Phyto” means plant, and also sometimes, it can be signified as cell- like. The development of phytosomes produces a little cell by itself, by which the active ingredient of the herbal extracts is protected from the intestinal secretions and instinctive bacteria destruction. The introduction of phyto- somes into herbal formulation is very recent and useful because they have advanced bioavailability, and they are better absorbed. Also, they consume this enhanced ability to cross lipid-rich bio membranes to finally reach the blood. Phytosomes can also be defined as complex chemical mixtures which are formulated by countering more than one mole synthetic or natural phos- pholipids phosphatidyl ethanolamine or phosphatidylserines with the one mole of another component. There are various plants materials which can be merged in the process of phytosomes, such as several herbal extracts includ- ing quercetin, grape seed, Rhein, neem, green tea, aloe vera, marigold and ginseng. The bioavailability of phytosomes further as linked to conventional herbal extracts because it has enhanced capability to penetrate the lipid bio membrane to finally reach the systemic blood circulation. Phytosomes has been categorized as a novel line for herbal drug delivery. Various conven- tional dosage forms such as gels and creams remained expressed using these constituents, but they appeared to be a better dermatological effect. Hence, phytosomes were formulated by binding phosphatidylcholine (acts as a trans- porter and protect the skin) and herbal extracts. They consist of a phospho- lipid molecular structure which includes two fat-soluble tails and a water- soluble head, and because of its dual solubility, it was absorbed better and was also used for the treatment of skin carcinomas, antiaging and skin disorders.
Full text article
References
S Bhattacharya and A Ghosh. “Phytosomes: the Emerging Technology for Enhancement of Bioavailability of Botanicals and Nutraceuticals”. The Internet Journal of Aesthetic and Antiaging Medici 2(1) (2009), pp. 141–153.
E Bombardelli and M Spelta. “Phospholipid-polyphenol complex: A new concept in skin care ingredients”. Cosmetics Toiletries 106 (1991), pp. 69–76.
A Busby et al. “The use of a silymarin/phospholipids compound as a fetoprotectant from ethanol-induced behavioural deficits”. Journal of Herbal Pharmacotherapy 2(1) (2002), pp. 39–47.
A Goyal et al. “Potential of novel drug delivery systems for herbal drugs”. Indian journal of pharmaceutical education and research 45 (2011), pp. 225–235.
La Grange et al. “Protective effects of the flavonoids mixture, silymarin, on fetal rat brain and liver”. Journal of Ethnopharmacology 65 (1999), pp. 53–61.
N K Gupta and V K Dixit. “Development and evaluation of vesicular system for curcumin delivery”. Archieves of Dermatological Research 303 (2011), pp. 89–101.
Y N Jiang et al. “Studies on preparation of herba epimedii flavanoid phytosomes and their pharmaceutics”. Zhongguo Zhong Yao Za Zhi 26(2) (2001), pp. 105–113.
Divyanshu Keshawn, Arindam Sharma, and Manish Jaimini Chatterjee. “Phytosomes: A promising system of herbal drug delivery”. Journal of Chemical and Pharmaceutical Research 8(1) (2016), pp. 804–808.
P M Kidd and K Head. “A review of the bioavailability and clinical efficacy of milk thistle Phytosome: a silybinphosphatidylcholine complex”. Alternative Medicine Review 10(3) (2005), pp. 193–203.
Arun Kumar et al. Saurabh Singh A Review On Phytosomes: Novel Approach For Herbal Phytochemicals, Asian Journal Of Pharmaceutical and Clinical Research 10(10) (2017).
G M El Maghraby, A C Williams, and B W Barry. “Oestradiol skin delivery from ultradeformable liposomes: Refinement of surfactant concentration”. Int J Pharm 196(1) (2000), pp. 63–74.
K Maiti et al. “Enhanced therapeutic benefit of quercetinphospholipid complex in carbon tetrachloride induced acute liver injury in rats: a comparative study”. Iranian Journal of Pharmacology & Therapeutics 4 (2005), pp. 84–90.
S Mascarella. “Therapeutic and antilipoperoxidant effects of silybin-phosphatidylcholine complex in chronic liver disease, Preliminary results”. Current Therapeutic Research 53(1) (1993), pp. 98–102.
P K Mukherjee and A Wahile. “Integrated Approaches towards drug development from Ayurveda and other Indian System of Medicine”. Journal of Ethnopharmacology 103 (2006), pp. 25–35.
S R Naik and V S Panda. “Hepatoprotective effect of Ginkgoselect Phytosome in rifampicin induced liver injury in rats: evidence of antioxidant activity”. Fitoterapia 79(6) (2008), pp. 439–445.
R Schandalik and E Perucca. “Pharmacokinetics of silybin following oral administration of silipide in patients with extrahepatic biliary obstruction”. Drugs under Experimental & Clinical Research 20 (1994).
A Semalty, M Semalty, and Msm Rawat. “The phyto-phospholipid complexes- phytosomes: a potential therapeutic approach for herbal hepatoprotective drug delivery”. Pharmacognosy Reviews 1(2) (2007), pp. 369–374.
R P Singh, V H Gangadharappa, and K Mruthunjaya. “Phytosome loaded novel herbal drug delivery system: A review”. Int Res J Pharm 7(6) (2016), pp. 15–21.
Surendra Tripathi et al. “A Review On Phytosomes, Their Characterization, Advancement & Potential For Transdermal Application”. Journal of Drug Delivery & Therapeutics 3(3) (2013), pp. 147–152.
Xiao Yanyu et al. “The preparation of silybin-phospholipid complex and the study on its pharmacokinetics in rats”. International Journal of Pharmaceutics 307 (2006), pp. 77–82.
Authors
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Article Details
